Nomura Asset Management CO LTD Horizon Therapeutics Public LTD CO Transaction History

Nomura Asset Management CO LTD

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 03, 2023	SELL	$98.98 - $115.74 $58,398 - $68,286	-590 Reduced 1.13%	51,730 $5.98 Million
Q1 2023 May 11, 2023	BUY	$107.32 - $113.5 $166,024 - $175,584	1,547 Added 3.05%	52,320 $5.71 Million
Q4 2022 Feb 14, 2023	BUY	$62.39 - $113.8 $177,998 - $324,671	2,853 Added 5.95%	50,773 $5.78 Million
Q2 2022 Aug 12, 2022	BUY	$79.4 - $116.36 $208,425 - $305,445	2,625 Added 5.8%	47,920 $3.82 Million
Q1 2022 May 13, 2022	BUY	$86.42 - $109.81 $268,939 - $341,728	3,112 Added 7.38%	45,295 $4.77 Million
Q4 2021 Feb 01, 2022	BUY	$98.56 - $119.91 $112,555 - $136,937	1,142 Added 2.78%	42,183 $4.55 Million
Q3 2021 Nov 12, 2021	SELL	$91.91 - $110.37 $277,568 - $333,317	-3,020 Reduced 6.85%	41,041 $4.5 Million
Q2 2021 Aug 06, 2021	BUY	$86.24 - $95.92 $437,323 - $486,410	5,071 Added 13.01%	44,061 $4.13 Million
Q1 2021 May 14, 2021	BUY	$71.83 - $95.48 $35,915 - $47,740	500 Added 1.3%	38,990 $3.59 Million
Q4 2020 Feb 12, 2021	BUY	$67.0 - $84.39 $2.58 Million - $3.25 Million	38,490 New	38,490 $2.82 Million
Q3 2020 Nov 12, 2020	BUY	$55.23 - $79.93 $0 - $0	0 New	0 $0
Q2 2020 Aug 13, 2020	BUY	$30.2 - $56.98 $0 - $0	0 New	0 $0

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Nomura Asset Management CO LTD, based on Form 13F filings with the SEC.

Stay updated on Nomura Asset Management CO LTD with notifications on news.